Published in Am J Physiol Renal Physiol on March 23, 2004
Arginine, arginine analogs and nitric oxide production in chronic kidney disease. Nat Clin Pract Nephrol (2006) 1.40
Renal disease in rats with type 2 diabetes is associated with decreased renal nitric oxide production. Diabetologia (2004) 0.97
Role of pendrin in iodide balance: going with the flow. Am J Physiol Renal Physiol (2009) 0.93
Resistance to renal damage by chronic nitric oxide synthase inhibition in the Wistar-Furth rat. Am J Physiol Regul Integr Comp Physiol (2006) 0.87
Chronic nitric oxide deficiency and progression of kidney disease after renal mass reduction in the C57Bl6 mouse. Am J Nephrol (2010) 0.87
Nephron number determines susceptibility to renal mass reduction-induced CKD in Lewis and Fisher 344 rats: implications for development of experimentally induced chronic allograft nephropathy. Nephrol Dial Transplant (2008) 0.86
Renal nitric oxide production in rat pregnancy: role of constitutive nitric oxide synthases. Am J Physiol Renal Physiol (2010) 0.84
Arginine and asymmetric dimethylarginine in puromycin aminonucleoside-induced chronic kidney disease in the rat. Am J Nephrol (2011) 0.82
Telmisartan protects 5/6 Nx rats against renal injury by enhancing nNOS-derived NO generation via regulation of PPARγ signaling. Am J Transl Res (2014) 0.81
Strain of experimental animals and modulation of nitric oxide pathway: their influence on development of renal failure in an experimental model of hepatorenal syndrome. Arch Med Sci (2012) 0.79
Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods (2001) 414.27
Hyperfiltration in remnant nephrons: a potentially adverse response to renal ablation. Am J Physiol (1981) 4.75
Nitric oxide synthase generates superoxide and nitric oxide in arginine-depleted cells leading to peroxynitrite-mediated cellular injury. Proc Natl Acad Sci U S A (1996) 3.29
Total nitric oxide production is low in patients with chronic renal disease. Kidney Int (2000) 2.11
Chronic nitric oxide inhibition model six years on. Hypertension (1998) 1.72
Protein interactions with nitric oxide synthases: controlling the right time, the right place, and the right amount of nitric oxide. Am J Physiol Renal Physiol (2003) 1.63
Animal models of FSGS: lessons for pathogenesis and treatment. Semin Nephrol (2003) 1.47
Nephron mass as a risk factor for progression of renal disease. Kidney Int Suppl (1997) 1.39
Acute changes in urinary excretion of nitrite + nitrate do not necessarily predict renal vascular NO production. Kidney Int (1995) 1.35
Experimental model of focal sclerosis. I. Relationship to protein excretion in aminonucleoside nephrosis. Lab Invest (1977) 1.28
Renal and systemic nitric oxide synthesis in rats with renal mass reduction. Kidney Int (1997) 1.27
Skeletal muscle contractions stimulate cGMP formation and attenuate vascular smooth muscle myosin phosphorylation via nitric oxide. FEBS Lett (1998) 1.23
Induction of nitric oxide synthase mRNA expression. Suppression by exogenous nitric oxide. J Biol Chem (1995) 1.21
Protection of wistar furth rats from chronic renal disease is associated with maintained renal nitric oxide synthase. J Am Soc Nephrol (2003) 1.21
Sexual dimorphism in the aging kidney: Effects on injury and nitric oxide system. Kidney Int (2003) 1.19
Nitric oxide modulates vascular disease in the remnant kidney model. Am J Pathol (2002) 1.19
Nitric oxide production is low in end-stage renal disease patients on peritoneal dialysis. Am J Physiol (1999) 1.18
Uremic levels of BUN do not cause nitric oxide deficiency in rats with normal renal function. Am J Physiol Renal Physiol (2001) 1.17
Serial micropuncture analysis of glomerular function in two rat models of glomerular sclerosis. J Clin Invest (1988) 1.17
Renal neuronal nitric oxide synthase protein expression as a marker of renal injury. Kidney Int (2003) 1.16
Oral administration of L-arginine and captopril in rats prevents chronic renal failure by nitric oxide production. Kidney Int (1995) 1.15
Downregulation of nitric oxide synthase in chronic renal insufficiency: role of excess PTH. Am J Physiol (1998) 1.14
Indices of activity of the nitric oxide system in hemodialysis patients. Am J Kidney Dis (1999) 1.14
Focal and segmental glomerulosclerosis following a single intravenous dose of puromycin aminonucleoside. Am J Pathol (1986) 1.08
Feedback control of glomerular vascular tone in neuronal nitric oxide synthase knockout mice. J Am Soc Nephrol (2001) 1.07
Chronic nitric oxide synthase inhibition aggravates glomerular injury in rats with subtotal nephrectomy. J Am Soc Nephrol (1995) 1.05
Neural nitric oxide synthase in the renal medulla and blood pressure regulation. Hypertension (1996) 1.04
Analysis of renal structural and functional features in two rat strains with a different susceptibility to glomerular sclerosis. Lab Invest (1986) 1.04
Mechanisms underlying transition from acute glomerular injury to late glomerular sclerosis in a rat model of nephrotic syndrome. J Clin Invest (1988) 1.03
Reduced nitric oxide synthase activity in rats with chronic renal disease due to glomerulonephritis. Kidney Int (2002) 1.01
Increased blood pressure in rats after long-term inhibition of the neuronal isoform of nitric oxide synthase. J Clin Invest (1997) 0.99
Downregulation of neuronal nitric oxide synthase in the rat remnant kidney. J Am Soc Nephrol (1999) 0.97
Downregulation of nitric oxide synthase in nephrotic syndrome: role of proteinuria. Biochim Biophys Acta (2003) 0.89
Lack of a role for inducible nitric oxide synthase in an experimental model of nephrotic syndrome. Biochem Pharmacol (2000) 0.89
Role of neuronal nitric oxide synthase in the macula densa. Kidney Int (2001) 0.88
Nitric oxide and tubuloglomerular feedback. Semin Nephrol (1999) 0.88
Dietary supplementation with L-arginine ameliorates glomerular hypertension in rats with subtotal nephrectomy. J Am Soc Nephrol (1994) 0.87
Resistance to remnant nephropathy in the Wistar-Furth rat. J Am Soc Nephrol (1999) 0.87
Down-regulation of neuronal nitric oxide synthase by nitric oxide after oxygen-glucose deprivation in rat forebrain slices. J Neurochem (1999) 0.87
Evidence for the existence of two distinct functions for the inducible NO synthase in the rat kidney: effect of aminoguanidine in rats with 5/6 ablation. J Am Soc Nephrol (2002) 0.85
Resistance to mineralocorticoids in Wistar-Furth rats. Am J Physiol (1997) 0.85
Differences in puromycin aminonucleoside nephrosis in two rat strains. Kidney Int (1988) 0.84
Temocapril, a long-acting non-SH group angiotensin converting enzyme inhibitor, modulates glomerular injury in chronic puromycin aminonucleoside nephrosis. J Nephrol (2002) 0.77
Outcomes of kidney transplantation in HIV-infected recipients. N Engl J Med (2010) 6.26
Hyperuricemia as a mediator of the proinflammatory endocrine imbalance in the adipose tissue in a murine model of the metabolic syndrome. Diabetes (2011) 1.82
Comorbid conditions, treatment, and health maintenance in older persons with human immunodeficiency virus infection in New York City. Clin Infect Dis (2002) 1.73
Uric acid decreases NO production and increases arginase activity in cultured pulmonary artery endothelial cells. Am J Physiol Cell Physiol (2008) 1.69
Matrix metalloproteinase 2 and basement membrane integrity: a unifying mechanism for progressive renal injury. FASEB J (2006) 1.59
Cereal, fruit, and vegetable fiber intake and the risk of cardiovascular disease in elderly individuals. JAMA (2003) 1.54
Demographic differences in the development of lupus nephritis: a retrospective analysis. Am J Med (2002) 1.45
Vascular localization of soluble epoxide hydrolase in the human kidney. Am J Physiol Renal Physiol (2003) 1.25
Characterization of blood pressure and morphological traits in cardiovascular-related organs in 13 different inbred mouse strains. J Appl Physiol (1985) (2004) 1.21
Protection of wistar furth rats from chronic renal disease is associated with maintained renal nitric oxide synthase. J Am Soc Nephrol (2003) 1.21
Splice variants of neuronal nitric oxide synthase are present in the rat kidney. Nephrol Dial Transplant (2008) 1.21
Asymmetric dimethylarginine in angiotensin II-induced hypertension. Am J Physiol Regul Integr Comp Physiol (2009) 1.20
Vitamin E reduces glomerulosclerosis, restores renal neuronal NOS, and suppresses oxidative stress in the 5/6 nephrectomized rat. Am J Physiol Renal Physiol (2007) 1.19
Sexual dimorphism in the aging kidney: Effects on injury and nitric oxide system. Kidney Int (2003) 1.19
Effect of reduced renal mass on renal ammonia transporter family, Rh C glycoprotein and Rh B glycoprotein, expression. Am J Physiol Renal Physiol (2007) 1.19
Renal neuronal nitric oxide synthase protein expression as a marker of renal injury. Kidney Int (2003) 1.16
Reversible cell-cycle entry in adult kidney podocytes through regulated control of telomerase and Wnt signaling. Nat Med (2011) 1.12
Peroxisome proliferator-activated receptor [gamma] agonist provides superior renal protection versus angiotensin-converting enzyme inhibition in a rat model of type 2 diabetes with obesity. J Pharmacol Exp Ther (2003) 1.05
Increased activity of cGMP-specific phosphodiesterase (PDE5) contributes to resistance to atrial natriuretic peptide natriuresis in the pregnant rat. J Am Soc Nephrol (2004) 1.03
Twelve weeks of treadmill exercise does not alter age-dependent chronic kidney disease in the Fisher 344 male rat. J Physiol (2011) 1.01
Reduced nitric oxide synthase activity in rats with chronic renal disease due to glomerulonephritis. Kidney Int (2002) 1.01
Increased renal phosphodiesterase-5 activity mediates the blunted natriuretic response to ANP in the pregnant rat. Am J Physiol Renal Physiol (2006) 0.99
The systemic lupus erythematosus-associated PDCD1 polymorphism PD1.3A in lupus nephritis. Arthritis Rheum (2004) 0.98
Race/ethnicity and disease severity in IgA nephropathy. BMC Nephrol (2004) 0.97
In vivo renal arginine release is impaired throughout development of chronic kidney disease. Am J Physiol Renal Physiol (2009) 0.96
Hepatitis B virus and hepatitis C virus services offered by substance abuse treatment programs in the United States. J Subst Abuse Treat (2011) 0.96
Relaxin ameliorates hypertension and increases nitric oxide metabolite excretion in angiotensin II but not N(ω)-nitro-L-arginine methyl ester hypertensive rats. Hypertension (2011) 0.96
Reliability of whole slide images as a diagnostic modality for renal allograft biopsies. Hum Pathol (2012) 0.95
Renal cortex neuronal nitric oxide synthase in response to rapamycin in kidney transplantation. Nitric Oxide (2007) 0.95
Physiological and molecular mechanisms governing sexual dimorphism of kidney, cardiac, and vascular function. Am J Physiol Regul Integr Comp Physiol (2006) 0.93
Attenuation of cisplatin-induced renal injury by inhibition of soluble epoxide hydrolase involves nuclear factor κB signaling. J Pharmacol Exp Ther (2012) 0.92
Maternal engineered nanomaterial exposure and fetal microvascular function: does the Barker hypothesis apply? Am J Obstet Gynecol (2013) 0.92
Dietary phosphorus transcriptionally regulates 25-hydroxyvitamin D-1alpha-hydroxylase gene expression in the proximal renal tubule. Endocrinology (2002) 0.92
Hyperbaric oxygen therapy mediates increased nitric oxide production associated with wound healing: a preliminary study. Adv Skin Wound Care (2007) 0.92
Protection against age-dependent renal injury in the F344xBrown Norway male rat is associated with maintained nitric oxide synthase. Mech Ageing Dev (2010) 0.90
Animal models of preeclampsia. Semin Nephrol (2004) 0.90
Epoxyeicosatrienoic acids prevent cisplatin-induced renal apoptosis through a p38 mitogen-activated protein kinase-regulated mitochondrial pathway. Mol Pharmacol (2013) 0.89
Effects of sildenafil on maternal hemodynamics and fetal growth in normal rat pregnancy. Am J Physiol Regul Integr Comp Physiol (2009) 0.88
Is HIV infection a risk factor for complications of surgery? Mt Sinai J Med (2002) 0.87
DOCA/NaCl-induced chronic kidney disease: a comparison of renal nitric oxide production in resistant and susceptible rat strains. Am J Physiol Renal Physiol (2006) 0.87
Resistance to renal damage by chronic nitric oxide synthase inhibition in the Wistar-Furth rat. Am J Physiol Regul Integr Comp Physiol (2006) 0.87
Vascular smooth muscle Jak2 mediates angiotensin II-induced hypertension via increased levels of reactive oxygen species. Cardiovasc Res (2011) 0.87
Chronic nitric oxide deficiency and progression of kidney disease after renal mass reduction in the C57Bl6 mouse. Am J Nephrol (2010) 0.87
Nephron number determines susceptibility to renal mass reduction-induced CKD in Lewis and Fisher 344 rats: implications for development of experimentally induced chronic allograft nephropathy. Nephrol Dial Transplant (2008) 0.86
Nebivolol does not protect against 5/6 ablation/infarction induced chronic kidney disease in rats - comparison with angiotensin II receptor blockade. Life Sci (2012) 0.86
The 'intestinal-renal' arginine biosynthetic axis in the aging rat. Mech Ageing Dev (2002) 0.86
Intravenous bilirubin provides incomplete protection against renal ischemia-reperfusion injury in vivo. Am J Physiol Renal Physiol (2006) 0.85
Repetitive-sequence-based PCR using the DiversiLab system for identification of Aspergillus species. J Clin Microbiol (2008) 0.85
Renal nitric oxide production in rat pregnancy: role of constitutive nitric oxide synthases. Am J Physiol Renal Physiol (2010) 0.84
Dissecting the causes of oxidative stress in an in vivo model of hypertension. Hypertension (2006) 0.84
Increased renal phosphodiesterase-5 activity mediates the blunted natriuretic response to a nitric oxide donor in the pregnant rat. Am J Physiol Renal Physiol (2010) 0.84
Endothelial health and diversity in the kidney. J Am Soc Nephrol (2006) 0.84
Urea transporters are distributed in endothelial cells and mediate inhibition of L-arginine transport. Am J Physiol Renal Physiol (2002) 0.84
The natriuretic and diuretic response to dopamine is maintained during rat pregnancy. Am J Physiol Renal Physiol (2008) 0.83
Reciprocal changes of renal neuronal nitric oxide synthase-α and -β associated with renal progression in a neonatal 5/6 nephrectomized rat model. Pediatr Neonatol (2011) 0.83
Lack of long-term protective effect of antioxidant/anti-inflammatory therapy in transplant-induced ischemia/reperfusion injury. Am J Nephrol (2006) 0.82
Impact of the estrus cycle and reduction in estrogen levels with aromatase inhibition, on renal function and nitric oxide activity in female rats. Steroids (2010) 0.82
Retracted Peroxynitrite versus nitric oxide in early diabetes. Am J Hypertens (2003) 0.82
Independent state health surveys: responding to the need for local population health data. J Public Health Manag Pract (2014) 0.82
Arginine and asymmetric dimethylarginine in puromycin aminonucleoside-induced chronic kidney disease in the rat. Am J Nephrol (2011) 0.82
Sirolimus delays recovery of rat kidney transplants after ischemia-reperfusion injury. Transplantation (2003) 0.82
Inhibition of inducible nitric oxide synthase during high dietary salt intake. Am J Hypertens (2002) 0.81
Daily versus thrice-weekly interferon alfa-2b plus ribavirin for the treatment of chronic hepatitis C in HIV-infected persons: a multicenter randomized controlled trial. J Acquir Immune Defic Syndr (2004) 0.81
Hormone replacement therapy and the risk of incident congestive heart failure: the Cardiovascular Health Study. J Womens Health (Larchmt) (2003) 0.81
Renal redox response to normal pregnancy in the rat. Am J Physiol Regul Integr Comp Physiol (2013) 0.80
Sexual dimorphism in development of kidney damage in aging Fischer-344 rats. Gend Med (2012) 0.80
Protective actions of nebivolol on chronic nitric oxide synthase inhibition-induced hypertension and chronic kidney disease in the rat: a comparison with angiotensin II receptor blockade. Nephrol Dial Transplant (2011) 0.79
Sleep and daytime sleepiness of patients with left ventricular assist devices: a longitudinal pilot study. Prog Transplant (2011) 0.79
Hyperbilirubinemia's protective effect against cisplatin nephrotoxicity in the Gunn rat. Anticancer Drugs (2008) 0.78
Sex differences in response to cyclosporine immunosuppression in experimental kidney transplantation. Clin Exp Pharmacol Physiol (2007) 0.78
"What made me stay?" A review of the reasons student nurses enrolled in a Bachelor of Nursing programme completed their studies: a descriptive phenomenological study. Nurse Educ Today (2012) 0.78
Chronic vasodilation produces plasma volume expansion and hemodilution in rats: consequences of decreased effective arterial blood volume. Am J Physiol Renal Physiol (2010) 0.77
Effects of angiotensin type 1 receptor blockade on arginine and ADMA synthesis and metabolic pathways in fawn-hooded hypertensive rats. Nephrol Dial Transplant (2010) 0.77
Effects of voluntary wheel running on the kidney at baseline and after ischaemia-reperfusion-induced acute kidney injury: a strain difference comparison. J Physiol (2012) 0.77
Renal nitric oxide synthase and antioxidant preservation in Cyp1a1-Ren-2 transgenic rats with inducible malignant hypertension. Am J Hypertens (2013) 0.77
Aldosterone antagonists in monotherapy are protective against streptozotocin-induced diabetic nephropathy in rats. PLoS One (2012) 0.77
Clinical pharmacist intervention for patients with left ventricular assist devices. Ann Pharmacother (2011) 0.76
Hyaline arteriolosclerosis: new meaning for an old lesion. Kidney Int (2003) 0.75
An emerging role for relaxin as a renal vasodilator. J Am Soc Nephrol (2006) 0.75
Chronic vasodilation increases renal medullary PDE5A and α-ENaC through independent renin-angiotensin-aldosterone system pathways. Am J Physiol Regul Integr Comp Physiol (2013) 0.75
Matrix Extension Study: Validation of the Compact Dry TC Method for Enumeration of Total Aerobic Bacteria in Selected Foods. J AOAC Int (2016) 0.75
Peroxynitrite versus nitric oxide in early diabetes. Am J Hypertens (2008) 0.75
Polypharmacy reduction in youth in a residential treatment center leads to positive treatment outcomes and significant cost savings. J Child Adolesc Psychopharmacol (2013) 0.75
Matrix Extension Study: Validation of the Compact Dry CF Method for Enumeration of Total Coliform Bacteria in Selected Foods. J AOAC Int (2016) 0.75
A bounding estimate of neutron dose based on measured photon dose around single pass reactors at the Hanford site. Health Phys (2010) 0.75
Renal insufficiency with monoclonal gammopathy and urticarial vasculitis. Am J Kidney Dis (2002) 0.75
Acute felbamate overdose with crystalluria. Clin Toxicol (Phila) (2005) 0.75
An exploratory study of sleep quality, daytime function, and quality of life in patients with mechanical circulatory support. Int J Artif Organs (2012) 0.75
Matrix Extension Study: Validation of the Compact Dry EC Method for Enumeration of Escherichia coli and non-E. coli Coliform Bacteria in Selected Foods. J AOAC Int (2016) 0.75
Medications and cardiovascular health in older adults: room for improvement in prevention and treatment. Am J Geriatr Cardiol (2004) 0.75
States' use of local population health data: comparing the Behavioral Risk Factor Surveillance System and independent state health surveys. J Public Health Manag Pract (2013) 0.75